Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The increased expression level of CASC4 is associated with HER-2\\/neu proto-oncogene overexpression. Additionally we are shipping Cancer Susceptibility Candidate 4 Proteins (5) and many more products for this protein.
Showing 10 out of 24 products:
Human Polyclonal CASC4 Primary Antibody for EIA, WB - ABIN951049
Sato, Peiper, Heinecke, Zurakowski, Eisenberger, Hosch, Knoefel, Izbicki: Expression of HER2/neu does not correlate with survival in soft tissue sarcoma. in Onkologie 2003
Show all 4 references for ABIN951049
In spite of missing correlation between survival and her-2/ neu (show ERBB2 Antibodies) overexpression in our study, the predictive value of the her-2/ neu (show ERBB2 Antibodies) protooncogene in adjuvant therapy in OSCC needs further investigation.
Of 62 analyzed specimens, 43 tumors were HER2/neu (show ERBB2 Antibodies) negative compared to 19 HER2/neu (show ERBB2 Antibodies) positive tumors. Kaplan-Meier analysis indicated no difference in survival according to HER2/neu (show ERBB2 Antibodies) expression (p = 0.31, log-rank test = 1.10
The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30% of human breast and 20% of human ovarian cancers. Alternatively spliced variants encoding different isoforms have been identified for this gene.
cancer susceptibility candidate gene 4 protein
, gene associated with HER-2/neu overexpression
, protein CASC4
, cancer susceptibility candidate gene 4 protein homolog